Imara Reports Full Year 2020 Financial Results and Business Highlights
Significant progress advancing IMR-687 as an oral, once-a-day potentially disease modifying treatment for sickle cell disease and beta-thalassemiaReports new Phase...
Reports
Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Sale of Manufacturing Operations to Catalent with net proceeds of ~$74 millionAnnual operating expenses cut by ~$40 million via sale,...
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results
Enrollment ongoing in 3 Cellectis-sponsored Phase 1 dose-escalation trials BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and...
Grupo Aeroportuario del Pacifico Reports Passenger Traffic Decrease of 52.7% for the Month of February
GUADALAJARA, Mexico, March 04, 2021 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacifico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the...
Kadmon Provides Business Update and Reports Fourth Quarter 2020 Financial Results
NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today provided a business update and...
VYNE Therapeutics Reports Year-End 2020 Financial Results and Provides Business Update
Conference call and live webcast to discuss financial results and new FMX114 program in atopic dermatitis today, Thursday, March 4,...
argenx Reports Full Year 2020 Financial Results and Provides Fourth Quarter Business Update
- Biologics License Application (BLA) for IV efgartigimod accepted for review by U.S. Food and Drug Administration (FDA) for generalized...
Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
– Company on track to present data from Phase 2b ReDUX4 trial with losmapimod in facioscapulohumeral muscular dystrophy (FSHD) in...
Ciena Reports Fiscal First Quarter 2021 Financial Results | Business & Finance
HANOVER, Md.--(BUSINESS WIRE)--Mar 4, 2021--Ciena® Corporation (NYSE: CIEN), a networking systems, services and software company, today announced unaudited financial results...
Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update
FDA recommends we conduct a randomized, double-blinded, placebo-controlled Phase II for Intravenous (IV) and Inhaled Ampion to allow consideration of...
Target Corporation Reports Fourth Quarter and Full-Year 2020 Earnings
MINNEAPOLIS, March 2, 2021 /PRNewswire/ --Q4 2020 Highlights Comparable sales grew 20.5 percent, reflecting comparable traffic growth of 6.5 percent...
Orphazyme reports business highlights and financial results in Annual Report 2020
Orphazyme A/SCompany announcementNo. 06/2021Company Registration No. 32266355-Advanced arimoclomol in 4 rare disease indications; announced global brand name of arimoclomol (MIPLYFFATM1);...
Strategic Education, Inc. Reports Fourth Quarter 2020 Results; Solid Financial Foundation Entering 2021
Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced financial results for the period ended December 31, 2020."We are encouraged...
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
VXA-CoV2-1 oral COVID-19 vaccine candidate targeting both the S and N proteins is planned to advance to Phase 2 testing...
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Company demonstrates resilience despite COVID-19 challenges: Financial situation secure and development programs progressingConference call begins today at 4:30 p.m. (ET)BASKING...
Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates
2021 Vaccine Manufacturing: Raises lower end of global manufacturing plan for 2021 from 600 million doses to 700 million doses;...
BELLUS Health Reports Year 2020 Financial Results and Business Highlights
- Initiated the Phase 2b SOOTHE clinical trial in refractory chronic cough; topline results expected Q4 2021 with an interim...
ASUR Reports 4Q20 Financial Results
Passenger traffic continues to reflect travel disruptions worldwide due to the COVID-19 pandemicMEXICO CITY, Feb. 24, 2020 /PRNewswire/ -- Grupo...
